azacitidine has been researched along with B-Cell Leukemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boenisch, O; Bokemeyer, C; Fiedler, W; Ghandili, S; Ittrich, H; Jarczak, D; Karagiannis, P; Kluge, S; Lütgehetmann, M; Modemann, F; Pfefferle, S; Roedl, K; Rohde, H; Schmiedel, S; Sonnemann, P; Weisel, K; Wichmann, D | 1 |
| Boumber, Y; Fang, Z; Garcia-Manero, G; Gonzalez-Cervantes, EA; Kuang, SQ; Wei, Y; Yang, H; Zweidler-McKay, PA | 1 |
| Bhatla, T; Brown, P; Burke, MJ; Carroll, WL; Morrison, DJ; Raetz, EA; Wang, J | 1 |
| Airoldi, I; Amadori, A; Banelli, B; Cocco, C; Di Carlo, E; Moserle, L; Pezzolo, A; Pistoia, V; Romani, M; Rossi, E; Sorrentino, C | 1 |
| DeCastro, CM; Demakos, EP; Ellerton, J; Holland, JC; Holland, JF; Kornblith, AB; Larson, RA; Nelson, D; Odchimar-Reissig, R; Peterson, BL; Powell, BL; Schiffer, CA; Silverman, LR; Stone, RM | 1 |
| DeCastro, C; Demakos, EP; Ellerton, J; Herndon, JE; Holland, JC; Holland, JF; Kornblith, AB; Larson, RA; Odchimar-Reissig, R; Powell, BL; Schiffer, CA; Silverman, LR | 1 |
3 trial(s) available for azacitidine and B-Cell Leukemia
| Article | Year |
|---|---|
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Cell Line, Tumor; Child; Child, Preschool; Cohort Studies; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Leukemic; Gene Silencing; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leukemia, B-Cell; Male; Vorinostat | 2012 |
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blood Cell Count; Bone Marrow; Cross-Over Studies; Female; Humans; Injections, Subcutaneous; Leukemia, B-Cell; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Risk Factors; Treatment Outcome | 2002 |
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Female; Humans; Injections, Subcutaneous; Leukemia, B-Cell; Male; Middle Aged; Myelodysplastic Syndromes; Quality of Life; Remission Induction; Surveys and Questionnaires; Treatment Outcome | 2002 |
3 other study(ies) available for azacitidine and B-Cell Leukemia
| Article | Year |
|---|---|
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; COVID-19; Cytarabine; Extracorporeal Membrane Oxygenation; Female; Humans; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Topics: Apoptosis; Azacitidine; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Blood Cells; Bone Marrow; Calcium-Binding Proteins; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Silencing; Hematopoiesis; Histones; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Leukemia, B-Cell; Membrane Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Notch3; Receptors, Notch; Repressor Proteins; Serrate-Jagged Proteins; Signal Transduction; T-Lymphocytes; Transcription, Genetic; Vorinostat | 2013 |
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.
Topics: Animals; Azacitidine; B-Lymphocytes; Chronic Disease; Decitabine; DNA Modification Methylases; Genes, Tumor Suppressor; Humans; Interleukin-12; Leukemia, B-Cell; Lymphoproliferative Disorders; Mice; Mice, Inbred NOD; Mice, SCID; Palatine Tonsil; Receptors, Interleukin; Receptors, Interleukin-12 | 2004 |